SNES
SNES
NASDAQ · Pharmaceuticals

Senestech Inc

$1.77
-0.02 (-1.12%)
As of Mar 25, 5:40 PM ET ·
Financial Highlights (FY 2026)
Revenue
14.52M
Net Income
-48,346,397
Gross Margin
54.1%
Profit Margin
-333.0%
Rev Growth
+45.7%
D/E Ratio
0.10
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 54.1% 54.1% 62.8% 62.8%
Operating Margin -336.5% -302.9% 42.6% 41.5%
Profit Margin -333.0% -316.4% 36.3% 33.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 14.52M 9.96M 1.47M 1.59M
Gross Profit 7.85M 5.39M 923.2K 998.4K
Operating Income -48,854,878 -30,171,817 625.4K 659.9K
Net Income -48,346,397 -29,857,789 533.2K 527.1K
Gross Margin 54.1% 54.1% 62.8% 62.8%
Operating Margin -336.5% -302.9% 42.6% 41.5%
Profit Margin -333.0% -316.4% 36.3% 33.2%
Rev Growth +45.7% +45.7% +11.3% -5.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 445.8K 445.8K 2.27M 1.95M
Total Equity 4.27M 4.27M 4.98M 4.41M
D/E Ratio 0.10 0.10 0.46 0.44
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -47,619,019 -31,042,385 838.1K 900.8K
Free Cash Flow 521.2K 519.7K